ResMed Inc (RMD)
Quick ratio
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | US$ in thousands | 932,711 | 521,944 | 426,361 | 238,361 | 237,910 | 210,247 | 209,100 | 227,891 | 227,894 | 253,199 | 207,163 | 273,710 | 201,769 | 194,476 | 276,149 | 295,278 | 230,635 | 255,865 | 421,414 | 463,156 |
Short-term investments | US$ in thousands | — | — | — | 12,026 | 21,537 | 7,617 | 11,821 | 12,423 | 12,115 | 4,980 | — | 9,167 | 17,842 | 19,566 | 33,138 | — | 24,011 | — | 2,020 | — |
Receivables | US$ in thousands | 907,825 | 859,937 | 811,198 | 837,275 | 817,190 | 729,740 | 692,388 | 704,909 | 686,264 | 672,271 | 620,483 | 575,950 | 508,580 | 550,719 | 601,353 | 614,292 | 525,014 | 518,817 | 474,478 | 484,095 |
Total current liabilities | US$ in thousands | 940,516 | 851,960 | 904,079 | 910,655 | 773,030 | 764,073 | 770,802 | 758,533 | 761,691 | 732,714 | 692,659 | 689,299 | 667,265 | 621,064 | 624,158 | 911,766 | 876,541 | 577,335 | 590,853 | 602,761 |
Quick ratio | 1.96 | 1.62 | 1.37 | 1.19 | 1.39 | 1.24 | 1.18 | 1.25 | 1.22 | 1.27 | 1.19 | 1.25 | 1.09 | 1.23 | 1.46 | 1.00 | 0.89 | 1.34 | 1.52 | 1.57 |
March 31, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($932,711K
+ $—K
+ $907,825K)
÷ $940,516K
= 1.96
The quick ratio of ResMed Inc. demonstrates notable fluctuations over the analyzed period, indicating shifts in the company's short-term liquidity position. Starting from a relatively strong value of 1.57 as of June 30, 2020, the ratio experienced a gradual decline through December 31, 2020, reaching 1.34. This downward trend continued more markedly by March 31, 2021, with the ratio dropping to 0.89, reflecting a significant decrease in liquid assets relative to current liabilities.
Subsequently, the ratio recovered somewhat, rising back to 1.00 in June 2021 and further improving to 1.46 by September 2021, suggesting an enhancement in liquidity. The value slightly declined again to 1.23 at the end of 2021 and maintained a moderate level around 1.09 to 1.25 through June 2022 to September 2022. The ratio remained relatively stable during this period, indicating ongoing liquidity management.
Starting from the end of 2022, the ratio exhibited modest increases and decreases, generally staying above 1.2, with values like 1.27 at December 2022 and 1.22 in March 2023. A slight decrease occurred by June 2023 to 1.25, followed by a minor dip to 1.18 in September 2023. Notably, the ratio climbed again to 1.24 at the end of 2023 and showed upward momentum into early 2024, reaching 1.39 in March 2024, but then dipped to 1.19 by June 2024 before rising significantly to 1.37 in September 2024 and subsequently increasing to 1.62 at December 2024.
The most recent data point, as of March 31, 2025, indicates a further increase to 1.96, approaching nearly double the initial levels observed in 2020. This progression suggests a consistent strengthening of ResMed Inc.'s liquid asset position relative to its current liabilities in recent periods.
Overall, the trend of the quick ratio highlights periods of both liquidity strain and recovery, with recent data illustrating a marked improvement in the company's short-term liquidity profile, which may indicate enhanced financial resilience or improved management of quick assets relative to current liabilities.
Peer comparison
Mar 31, 2025